Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (41-50 of 414) with videos related to

Pageof 42
Sort By:
Bulletin of the NYU Hospital for Joint Diseases|October 27, 2009
Clinical trials for lupus--are we there yet?Joan T Merrill
Clinical Immunology (Orlando, Fla.)|May 18, 2013
Co-stimulatory molecules as targets for treatment of lupusJoan T Merrill
Current Rheumatology Reports|July 27, 2001
What causes the antiphospholipid syndrome?J T Merrill
The Journal of Rheumatology|November 5, 2002
Measuring disease activity in systemic lupus: progress and problemsJoan T Merrill
Current Rheumatology Reports|September 12, 2003
Etanercept in antiphospholipid syndromeJoan T Merrill
Current Rheumatology Reports|September 12, 2003
Mycophenolate mofetil in antiphospholipid syndromeJoan T Merrill
Current Rheumatology Reports|November 6, 2004
Diagnosis of the antiphospholipid syndrome: how far to go?Joan T Merrill
Current Rheumatology Reports|August 21, 2009
What was wrong and might now go right with clinical trials for lupus?Joan T Merrill
Expert Opinion on Investigational Drugs|June 5, 2003
Dehydroepiandrosterone, a sex steroid metabolite in development for systemic lupus erythematosusJoan T Merrill
Lupus|April 6, 2005
BLyS antagonists and peptide tolerance inductionJ T Merrill
Pageof 42

Showing results (41-50 of 414) with videos related to

Sort By:
Pageof 42
Bulletin of the NYU Hospital for Joint Diseases|October 27, 2009
Clinical trials for lupus--are we there yet?Joan T Merrill
Clinical Immunology (Orlando, Fla.)|May 18, 2013
Co-stimulatory molecules as targets for treatment of lupusJoan T Merrill
Current Rheumatology Reports|July 27, 2001
What causes the antiphospholipid syndrome?J T Merrill
The Journal of Rheumatology|November 5, 2002
Measuring disease activity in systemic lupus: progress and problemsJoan T Merrill
Current Rheumatology Reports|September 12, 2003
Etanercept in antiphospholipid syndromeJoan T Merrill
Current Rheumatology Reports|September 12, 2003
Mycophenolate mofetil in antiphospholipid syndromeJoan T Merrill
Current Rheumatology Reports|November 6, 2004
Diagnosis of the antiphospholipid syndrome: how far to go?Joan T Merrill
Current Rheumatology Reports|August 21, 2009
What was wrong and might now go right with clinical trials for lupus?Joan T Merrill
Expert Opinion on Investigational Drugs|June 5, 2003
Dehydroepiandrosterone, a sex steroid metabolite in development for systemic lupus erythematosusJoan T Merrill
Lupus|April 6, 2005
BLyS antagonists and peptide tolerance inductionJ T Merrill
Pageof 42